Fight Colorectal Cancer shared on LinkedIn:
“We’re proud to welcome six new endorsing organizations to the Colorectal Cancer Care Initiative (CRCCI)!
Please join us in welcoming the American Indian Cancer Foundation, BeastRob, Colon Cancer Alliance for Research and Education for Lynch Syndrome, New York Oncology Hematology, United Digestive, and Veridata Health.
Their perspectives, from community outreach and hereditary cancer to clinical care and data, strengthen our shared national effort to improve colorectal cancer care at every step.
CRCCI endorsers are united around measurable goals for timely screening, accurate diagnosis, and timely treatment.
Learn more about our newest endorsers and how your organization can join the initiative.”
What is the Colorectal Cancer Care Initiative?
It’s a national effort led by Fight CRC to improve colorectal cancer care by setting and advancing shared goals for screening, diagnosis, testing, and treatment.
GOAL 1: Timely Screening
- Achieve an 80% screening rate for average-risk patients.
- Ensure 80% of patients with an abnormal non-invasive screening test receive a follow-up colonoscopy within 90 days (3 months).
GOAL 2: Accurate, Informative Diagnosis and Timely Treatment Initiation
- Ensure 80% of patients diagnosed with CRC receive biomarker testing in accordance with NCCN Clinical Practice Guidelines (NCCN Guidelines®).
- Ensure 80% of patients diagnosed with CRC undergo germline genetic testing at the time of diagnosis.
- Ensure 80% of patients initiate treatment within six weeks of a CRC diagnosis.
You may also be interested in:
